Clinical Trial

Effect of Fenugreek Seed Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Fenugreek has been shown to have beneficial effects on various metabolic abnormalities associated with metabolic syndrome (MS). However, no clinical trials have evaluated its effect on all components of MS, insulin sensitivity, and insulin secretion. Therefore, the main objective of this study is to assess the effect of fenugreek seed administration versus placebo on the components of metabolic syndrome, insulin sensitivity, and insulin secretion.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-29.
Trial Details
NCT Number NCT07056712
Lead Sponsor University of Guadalajara
Conditions Metabolic Syndrome
Enrollment 28 participants
Start Date 2025-09-15
Primary Completion 2026-09-15 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-08